Subgaleal EEG for Epilepsy
(TRCE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
TRACE is a record-only study evaluating subgaleal EEG (sgEEG) recorded concurrently with standard-of-care stereoelectroencephalography (SEEG) in adults with drug-resistant epilepsy undergoing inpatient epilepsy monitoring. The study will assess the ability of sgEEG to detect seizures and characterize seizure timing, signal quality and stability, and lateralization compared with SEEG.
Are You a Good Fit for This Trial?
This trial is for adults with drug-resistant epilepsy who are already scheduled to have inpatient SEEG monitoring as part of their standard care. Participants must be able to undergo EEG recording during their hospital stay.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
The study is testing a new way of recording brain signals called subgaleal EEG (sgEEG) at the same time as the usual SEEG monitoring, without adding any treatments or changes to patient care.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Record only
Find a Clinic Near You
Who Is Running the Clinical Trial?
Adraxe Corp.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.